R.H. Swift - Concepedia

Author

R.H. Swift

Pfizer (United States)

Also Known As

R. Swift, R.H Swift, R.H. Swift, Rachel H. Swift, Rachel Swift

Publications

655

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)PRA Health Sciences Sunovion (United States)

About

R.H. Swift is an author at Pfizer (United States) specializing in medicine, psychopathology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	352
2	Social Sciences	2	2	184
3	Behavioral Sciences	2	2	157
4	Anesthesia	1	1	11
5	Pharmacology	1	1	11

R.H. Swift

Publications

629

Citations

H-Index

Page 1

	Year	Citations
Intramuscular Ziprasidone, 2 mg Versus 10 mg, in the Short-Term Management of Agitated Psychotic Patients Michael D. Lesem, John Zajecka, R.H. Swift, The Journal of Clinical Psychiatry	2001	220
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial David G. Daniel, Steven G. Potkin, Karen R. Reeves, Psychopharmacology PsychiatryZiprasidone 20Psychotropic MedicationPsychotic DisorderPsychopharmacology	2001	174
Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patients R.H. Swift, Edmund P. Harrigan, Joseph C. Cappelleri, Journal of Psychiatric Research Physical ActivityBehavioral SciencesBehavioral MedicineBehavioral MeasurementBehavior-analytic Assessment	2002	146
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy David G. Daniel, Dan Zimbroff, R.H. Swift, International Clinical Psychopharmacology	2003	35
Ipecacuanha-induced emesis: A human model for testing antiemetic drug activity Neil Minton, R.H. Swift, Caroline Lawlor, Clinical Pharmacology & Therapeutics	1993	22
Validation of the behavioural activity rating scale (BARS): A novel measure of activity in agitated patients R.H. Swift, Edmund P. Harrigan, J.C. Cappelleri, European Neuropsychopharmacology Physical ActivityBehavioral SciencesBehavioral MeasurementBehavior-analytic AssessmentBehavior Monitoring	1998	11
A comparison of intramuscular (IM) ziprasidone with IM haloperidol R.H. Swift, Edmund P. Harrigan, Daniël P. van Kammen European Psychiatry MedicineFull PdfNeuropharmacologyPharmacotherapyIm Haloperidol	1998	11
A comparison of rapid-acting intramuscular (IM) ziprasidone 2 mg and 20 mg in patients with psychosis and acute agitation Karen R. Reeves, R.H. Swift, Edmund P. Harrigan European Psychiatry PsychiatryPsychotic DisorderPsychotropic MedicationFull PdfPsychopharmacology	1998	10

Page 1